|
|
 |
about £¾ Corporate Overview £¾ Highlight |
|
 |
|
|
 |
| |
Based on leading competitiveness in the prescription
drug market, Choongwae has built up strong sales
network across the country and superior pipelines
in I.V- solutions, antibiotic, cardiovascular, gastrointestinal,
nephrology/antianaemic, anticancer and neuropsychiatry.
And now, it is pioneering the rapidly growing new
field such as diabetes and so on.
Moreover, Choongwae is making efforts to provide
medical equipments, various self modification products
and OTC products satisfying the requirements for
prevention and diagnosis of diseases.
Also, Choongwae has diligently opened up itself
to the overseas market with competitive APIs (Active
Pharmaceutical Ingredients) and finished products
developed on a basis of our creative technologies.
Especially, the anti-fungal agents such as Ketoconazole
and Itraconazole are lively being exported to developed
countries such as EU, Japan with their acquisition
of EU CoS.
With an open mind even the competitors in the past
can become partners today,
Choongwae has been making steady progress having
the confidence that it can build up a win-win partnership
at anytime, with anyone and anywhere. |
|
|
|
|
|
| |
|
